Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q2 2017 · 10-Q
Revenue$75.73M$75.73M+6.4% vs Q2 2016 Net Income$7.58M$7.58M+123.3% vs Q2 2016 EPS Diluted$0.63$0.63+117.2% vs Q2 2016 Gross Profit$57,611,000+8.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$14,066,000+27.2% Free Cash Flowderived$13,516,000+30.1% Margins · derivedGross margin76.1%+1.3 pt vs Q2 2016
Operating margin14.9%+7.9 pt vs Q2 2016
Net margin10.0%+5.2 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 9, 2017 · 40 d after period end